Search

Author/Creator Schmidt, Emmett V.

1. A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Issue 5 (10th February 2023)

Authors:
Makker, Vicky; Aghajanian, Carol; Cohn, Allen L.; Romeo, Margarita; Bratos, Raquel; Brose, Marcia S.; Messing, Mark; Dutta, Lea; Dutcus, Corina E.; Huang, Jie; Schmidt, Emmett V.; Orlowski, Robert; Taylor, Matthew H.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 5(2023)
Page Start:
974
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Issue 20 (5th August 2020)

Authors:
Zhang, Tian; Harrison, Michael R.; O'Donnell, Peter H.; Alva, Ajjai S.; Hahn, Noah M.; Appleman, Leonard J.; Cetnar, Jeremy; Burke, John M.; Fleming, Mark T.; Milowsky, Matthew I.; Mortazavi, Amir; Shore, Neal; Sonpavde, Guru P.; Schmidt, Emmett V.; Bitman, Bojena; Munugalavadla, Veerendra; Izumi...
Journal:
Cancer
Issue:
Volume 126:Issue 20(2020)
Page Start:
4485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search